Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethosuximide for Chemotherapy-Induced Painful Peripheral Neuropathy
NCT01278004Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- May 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chemotherapy-induced peripheral neuropathy (CIPN) comparing Ethosuximide with Placebo (2 arms). Primary endpoint: Reduction in pain intensity at 6 weeks. Started May 2010; status: completed.
02
Drugs
ethosuximide
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT01278004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01278004.